EUVIMEDEUVIMED entdecken
Crossref

Current Roles of Ramucirumab in the Sequential Treatment of Unresectable Hepatocellular Carcinoma

Akira Koizumi, Shohei Komatsu, Satoshi Omiya, Yoshihiko Yano, Yoshimi Fujishima, Jun Ishida, Masahiro Kido, Hidetoshi Gon, Kenji Fukushima, Takeshi Urade, Shinichi So, Toshihiko Yoshida und 8 weitere

Anticancer Research · 2024

DOI: 10.21873/anticanres.17009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Akira Koizumi und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe University Graduate School of Medicine, Kobe, Japan. Hauptthemen laut MEDLINE: Ramucirumab, Carcinoma, Hepatocellular, Liver Neoplasms, Antibodies, Monoclonal, Humanized.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RamucirumabCarcinoma, HepatocellularLiver NeoplasmsAntibodies, Monoclonal, HumanizedQuinolinesalpha-FetoproteinsHumansMaleFemaleMiddle AgedAgedRetrospective StudiesPhenylurea CompoundsAged, 80 and overAntineoplastic AgentsTreatment OutcomeAdult

Stichwörter der Autor:innen

Liver functionhepatocellular carcinomaramucirumabrechallenge treatmentsequential treatment

Substanzen

RamucirumabAntibodies, Monoclonal, HumanizedlenvatinibQuinolinesalpha-FetoproteinsPhenylurea CompoundsAntineoplastic AgentsAFP protein, human

Autor:innen und Institutionen

  • Department of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Department of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe University Graduate School of Medicine, Kobe, Japan; komasho8@med.kobe-u.ac.jp.
  • Department of Internal Medicine, Division of Gastroenterology, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Division of Medical Oncology, Kobe Minimally Invasive Cancer Center, Kobe, Japan.
  • Division of Radiology, Kobe Minimally Invasive Cancer Center, Kobe, Japan.

Zitieren

APA

Koizumi, A., Komatsu, S., Omiya, S., Yano, Y., Fujishima, Y., Ishida, J., Kido, M., Gon, H., Fukushima, K., Urade, T., So, S., Yoshida, T., Arai, K., Fujinaka, R., Shimura, Y., Yanagimoto, H., Toyama, H., Ueda, Y., Kodama, Y., & Fukumoto, T. (2024). Current Roles of Ramucirumab in the Sequential Treatment of Unresectable Hepatocellular Carcinoma. Anticancer Research. https://doi.org/10.21873/anticanres.17009

Vancouver

Koizumi A, Komatsu S, Omiya S, Yano Y, Fujishima Y, Ishida J, et al. Current Roles of Ramucirumab in the Sequential Treatment of Unresectable Hepatocellular Carcinoma. Anticancer Research. 2024. doi:10.21873/anticanres.17009

BibTeX
@article{Koizumi2024,
  author = {Koizumi, Akira and Komatsu, Shohei and Omiya, Satoshi and Yano, Yoshihiko and Fujishima, Yoshimi and Ishida, Jun and Kido, Masahiro and Gon, Hidetoshi and Fukushima, Kenji and Urade, Takeshi and So, Shinichi and Yoshida, Toshihiko and Arai, Keisuke and Fujinaka, Ryosuke and Shimura, Yuhi and Yanagimoto, Hiroaki and Toyama, Hirochika and Ueda, Yoshihide and Kodama, Yuzo and Fukumoto, Takumi},
  title = {Current Roles of Ramucirumab in the Sequential Treatment of Unresectable Hepatocellular Carcinoma},
  journal = {Anticancer Research},
  year = {2024},
  doi = {10.21873/anticanres.17009}
}
Kostenlos starten →